Recent News

By Category: Biotechnology

Powerful New Approach to Attack Flu Virus

(Science Daily) An international research team has manufactured a new protein that can combat deadly flu epidemics. The paper, featured on the cover of the current issue of Nature Biotechnology, demonstrates ways to use manufactured genes as antivirals, which disable key functions of the flu virus, said Tim Whitehead, assistant professor of chemical engineering and Read More »

May 29, 2012
| Filed under Europe, Middle East, North America, Biotechnology, and Research
Share

Science Journal Produces a Different Kind of Viral Video

(MIT Technology Review) The world’s first peer-reviewed video journal gives scientists a better way to show others how to replicate experiments. If a photo is worth a thousand words, imagine the understanding that can be captured from 10 minutes at 30 frames per second. A scientific journal dedicated to video—a medium seldom seen in peer-reviewed Read More »

May 28, 2012
| Filed under Europe, North America, Biotechnology, International, and Research
Share

Detecting biological terror agents

(Homeland Security NewsWire) PositiveID Corporation is testing its M-BAND bioagent detection system in preparation for DHS’s $3 billion BioWatch procurement; M-BAND can be remotely set to detect for DNA-based pathogens alone, with or without either RNA-based organisms or toxins, or for all three types of pathogens simultaneously at remotely programmable intervals.

May 24, 2012
| Filed under North America, Biotechnology, Bioterrorism, Countermeasures, and Policy & Initiatives
Share

Darpa, Venter Launch Assembly Line for Genetic Engineering

(Danger Room) The military-industrial complex just got a little bit livelier. Quite literally. That’s because Darpa, the Pentagon’s far-out research arm, has kicked off a program designed to take the conventions of manufacturing and apply them to living cells. Think of it like an assembly line, but one that would churn out modified biological matter Read More »

May 24, 2012
| Filed under North America, Agents & Toxins, Biotechnology, and Research
Share

US Government Supports Phase 3 Study of Bavarian Nordic’s Smallpox Vaccine

(Press Release) Bavarian Nordic announced today that the U.S. Department of Health and Human Services has supported the initiation of an expanded Phase 3 study of IMVAMUNE® smallpox vaccine. The government is stockpiling 20 million doses of IMVAMUNE® under a Project BioShield contract for use in a potential smallpox emergency. The company’s procurement contract was Read More »